Compare PPCB & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PPCB | FOXX |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 16.9M |
| IPO Year | N/A | N/A |
| Metric | PPCB | FOXX |
|---|---|---|
| Price | $0.72 | $5.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 257.4K | ★ 2.9M |
| Earning Date | 11-17-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $63,030,415.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 139.29 |
| 52 Week Low | $0.72 | $1.71 |
| 52 Week High | $145.46 | $11.00 |
| Indicator | PPCB | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.00 |
| Support Level | N/A | $3.67 |
| Resistance Level | N/A | $6.30 |
| Average True Range (ATR) | 0.00 | 1.02 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 46.75 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.